Multivariable analysis of factors associated with nonadherence to primary prophylaxis against <i>Pneumocystis jirovecii</i> pneumonia (PCP) – Supplement to HIV/AIDS Surveillance (SHAS) project, 2000–2004.

*<p>In addition to adjusting for variables included in this table, we controlled for region of residence in the U.S. and year of SHAS interview.</p>†<p>P-value<0.05.</p

Primary reason for not taking medications to prevent <i>Pneumocystis jirovecii</i> pneumonia (PCP) listed by 264 persons who were nonadherent with primary PCP prophylaxis – Supplement to HIV/AIDS Surveillance (SHAS) project, 2000–2004.

<p>Primary reason for not taking medications to prevent <i>Pneumocystis jirovecii</i> pneumonia (PCP) listed by 264 persons who were nonadherent with primary PCP prophylaxis – Supplement to HIV/AIDS Surveillance (SHAS) project, 2000–2004.</p

Characteristics of 1,666 persons with HIV infection prescribed primary prophylaxis against <i>Pneumocystis jirovecii</i> pneumonia (PCP), by nonadherence to prophylaxis – Supplement to HIV/AIDS Surveillance (SHAS) project, 2000–2004.

*<p>Column percentages may not total 100% because of rounding.</p>†<p>P-value <0.05 when comparing persons nonadherent with those adherent to PCP prophylaxis.</p>‡<p>Regions defined by U.S. Census Bureau; for SHAS sites included in this analysis, Northeast comprises NJ, CT, and PA; South comprises GA, MD, FL, SC, DE, and TX; Midwest comprises IL, KS, MI, and MN; and West comprises AZ, CA, CO, NM, and WA.</p>±<p>Other responses included correctional institution, refused to answer, and other responses which did not fit into the listed response categories.</p>§<p>Categories are mutually exclusive.</p>||<p>Defined as answering yes to at least 2 of the CAGE screening questions and reporting alcohol use in the past year.</p

Characteristics of HIV care providers by testing behaviors – United States, Medical Monitoring Project Provider Survey, 2009.

*<p>Hispanic persons may be of any race.</p

Factors associated with HIV care providers offering HIV testing to all patients – United States, Medical Monitoring Project Provider Survey, 2009.

<p>Factors associated with HIV care providers offering HIV testing to all patients – United States, Medical Monitoring Project Provider Survey, 2009.</p

Medical Monitoring Project Data Domains, 2007*

*<p>Complete interview and chart abstraction instruments are available at: <a href="http://www.cdc.gov/hiv/topics/treatment/MMP/index.htm" target="_blank">http://www.cdc.gov/hiv/topics/treatment/MMP/index.htm</a></p

Racial/Ethnic Distribution of Adults* Living with HIV/AIDS in the United States, 2003, and in US HIV Cohorts, 2003-2006

*<p>Aged 13 and older in ASD and the US living HIV/AIDS cases, 18 and older in SHAS</p>†<p>Estimated number of persons living with HIV/AIDS at the end of 2003 from 33 areas with confidential name-based HIV infection reporting</p>‡<p>Not available: data on patients with Hispanic ethnicity are not reported in cohort profile <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0000550#pone.0000550-Gange1" target="_blank">[40]</a></p

Geographic distribution of US HIV clinical cohorts and Medical Monitoring Project data collection sites, 2007.

<p>Geographic distribution of US HIV clinical cohorts and Medical Monitoring Project data collection sites, 2007.</p

Medical Monitoring Project 3-stage sampling design.

<p>Medical Monitoring Project 3-stage sampling design.</p